STAAR Surgical Files Proxy Materials

TL;DR

STAAR Surgical filed proxy docs on 10/28, likely for shareholder votes.

AI Summary

STAAR Surgical Company filed a Definitive Additional Materials proxy statement on October 28, 2025, related to an email sent to employees on October 27, 2025. The filing is a standard DEFA14A, indicating it's a proxy statement for shareholder matters.

Why It Matters

This filing indicates ongoing corporate governance activities and shareholder communication for STAAR Surgical Company, which is relevant for investors tracking the company's operational and strategic updates.

Risk Assessment

Risk Level: low — This is a routine SEC filing (DEFA14A) and does not contain immediate financial or operational risks.

Key Players & Entities

• STAAR SURGICAL CO (company) — Registrant
• 0000718937 (company) — Central Index Key
• 1911 WALKER AVE (company) — Business Address
• MONROVIA (company) — City
• CA (company) — State
• 91016 (company) — ZIP Code
• 6263037902 (company) — Business Phone
• 20251028 (date) — Filing Date
• 20251028 (date) — Date as of Change
• 20251028 (date) — Submission Date

FAQ

Filing Documents

• d87705ddefa14a.htm (DEFA14A) — 19KB
• g87705g1008194101579.jpg (GRAPHIC) — 2KB
• g87705g1008194101767.jpg (GRAPHIC) — 2KB
• 0001193125-25-252202.txt ( ) — 26KB

Forward-Looking Statements

Forward-Looking Statements The information covered by this communication contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements often contain words such as "anticipate," "believe," "expect," "plan," "estimate," "project," "continue," "will," "should," "may," and similar terms. All statements in this communication that are not statements of historical fact are forward-looking statements. These forward-looking statements are neither promises nor guarantees and involve known and unknown risks, uncertainties and other important factors that may cause actual results, performance or achievements to be materially different from what is expressed or implied by the forward-looking statements, including, but not limited to: (1) the occurrence of any event, change or other circumstances that could give rise to the termination of the Alcon merger agreement or could cause the consummation of the proposed transaction to be delayed or to fail to occur; (2) the failure to obtain approval of the proposed transaction from STAAR's stockholders; (3) the failure to obtain certain required regulatory approvals or the failure to satisfy any of the other closing conditions to the completion of the proposed transaction within the expected timeframes or at all; (4) risks related to disruption of management's attention from STAAR's ongoing business operations due to the proposed transaction; (5) the effect of the announcement of the proposed transaction on the ability of STAAR to retain and hire key personnel and maintain relationships with its customers, suppliers and others with whom it does business, or on its operating results and business generally; (6) the ability of STAAR to meet expectations regarding the timing and completion of the transaction; (7) the outcome of any legal proceedings that may be instituted against STAAR related to the proposed transaction; (8) the possibility that STAAR's stock pr

View Full Filing

View this DEFA14A filing on SEC EDGAR